Clinical Trial Resource Center
FDA Drugs |
Research Headlines |
NMT Results |
Welcome to the Multiple Sclerosis Foundation Clinical Trials Resource Center,
presented in partnership with CenterWatch, the leading publisher of information on
clinical research for patients and their advocates and healthcare professionals. Please
click on the links below to learn more about clinical research and new medical therapies
for treating multiple sclerosis.
FDA Drug Approvals
This is a comprehensive listing of drugs that have recently been approved by the Food and
Drug Administration. The drugs are organized by therapeutic area.
CenterWatch Research Headlines
Here you'll find links to news articles and reports on recent advances in clinical
research. This section is updated weekly and the information has been published in
CenterWatch publications during the past weeks. There may not always be material
related to neurology indications.
New Medical Therapies (NMT) Trial Results
NMT Weekly Trial Results database is designed to provide easy access to information
about the results of recently completed and ongoing clinical trials and is based
on published materials from medical conferences and journals and from company
reports. The clinical trial result summaries typically include the name and phase
of the new therapy, the company sponsoring the research, a description of the trial
design, and information on how well the drug has performed.